Plus Therapeutics (NASDAQ:PSTV) Earns “Hold” Rating from D. Boral Capital
D. Boral Capital restated their hold rating on shares of Plus Therapeutics (NASDAQ:PSTV – Free Report) in a report released on Monday morning,Benzinga reports. A number of other research firms have also recently commented on PSTV. Ascendiant Capital Markets lifted their price target on shares of Plus Therapeutics from $19.00 to $20.00 and gave the […]
D. Boral Capital restated their hold rating on shares of Plus Therapeutics (NASDAQ:PSTV – Free Report) in a report released on Monday morning,Benzinga reports. A number of other research firms have also recently commented on PSTV. Ascendiant Capital Markets lifted their price target on shares of Plus Therapeutics from $19.00 to $20.00 and gave the […]
